IP Verse

Glaxosmithkline Biologicals Sa opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Glaxosmithkline Biologicals Sa

Patent Number:
EP3590949
Title:
Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses Thereof
Applicant:
MODERNATX, INC.
Opposition Date:
Feb 17, 2023
Patent Number:
EP3682905
Title:
Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
Applicant:
MODERNATX, INC.
Opposition Date:
Aug 26, 2022
Patent Number:
EP2970456
Title:
Methods And Compositions For Delivering Mrna Coded Antibodies
Applicant:
SHIRE HUMAN GENETIC THERAPIES, INC.
Opposition Date:
Feb 18, 2022
Patent Number:
EP3431485
Title:
Engineered Nucleic Acids And Methods Of Use Thereof
Applicant:
MODERNATX, INC.
Opposition Date:
Sep 30, 2021
Patent Number:
EP3489211
Title:
Improved Methods For Preparing Squalene
Applicant:
NOVARTIS AG
Opposition Date:
Apr 15, 2021
Patent Number:
EP3336082
Title:
Cleavable Lipids
Applicant:
TRANSLATE BIO, INC.
Opposition Date:
Jan 15, 2021
Patent Number:
EP2614835
Title:
Vaccination With Multiple Clades Of H5 Influenza A Virus
Applicant:
NOVARTIS AG
Opposition Date:
May 20, 2020
Patent Number:
EP3103784
Title:
Manufacture Of An Oil-In-Water Emulsion Comprising Squalene
Applicant:
NOVARTIS AG
Opposition Date:
Nov 6, 2019
Patent Number:
EP2968112
Title:
Stable Aqueous Formulations Of Adenovirus Vectors
Applicant:
ARECOR LIMITED
Opposition Date:
May 23, 2018

Latest patents of Glaxosmithkline Biologicals Sa opposed by its competitors

Patent:
EP4066819
Grant Date:
Mar 1, 2023
Title:
Small Liposomes For Delivery Of Immunogen-Encoding Rna
Oppositions:
4
Patent:
EP4043040
Grant Date:
Jan 11, 2023
Title:
Small Liposomes For Delivery Of Immunogen-Encoding Rna
Oppositions:
4
Patent:
EP4008357
Grant Date:
Dec 28, 2022
Title:
Small Liposomes For Delivery Of Immunogen-Encoding Rna
Oppositions:
4
Patent:
EP4066855
Grant Date:
Dec 28, 2022
Title:
Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna
Oppositions:
4
Patent:
EP4066857
Grant Date:
Dec 21, 2022
Title:
Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna
Oppositions:
4
Patent:
EP4066856
Grant Date:
Dec 7, 2022
Title:
Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna
Oppositions:
4
Patent:
EP2611467
Grant Date:
Jul 20, 2022
Title:
Small Liposomes For Delivery Of Immunogen-Encoding Rna
Oppositions:
5
Patent:
EP2611461
Grant Date:
Mar 9, 2022
Title:
Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna
Oppositions:
4
Patent:
EP2869841
Grant Date:
Aug 25, 2021
Title:
Novel Prime-Boosting Regimens Involving Immunogenic Polypeptides Encoded By Polynucleotides
Oppositions:
1
Patent:
EP2729126
Grant Date:
Dec 23, 2020
Title:
Liposomes Having Useful N:P Ratio For Delivery Of Rna Molecules
Oppositions:
4

Competitors of Glaxosmithkline Biologicals Sa

SANOFI

JG OPPOSITIONS LIMITED

WEICKMANN & WEICKMANN PARTMBB

Want to track Glaxosmithkline Biologicals Sa?

Feel free to send us a message here and we will get back to you